In baseline biopsies of a small cohort of NSCLC cancer, Lo Russo et al. have described that a subtype of clustered CD163+CD33+PD-L1+ macrophages with epithelioid morphology was significantly enriched in all hyperprogressor patients compared to patients not experiencing hyperprogression (84). The gene discussed is CD163; the disease is non-small cell lung carcinoma.